Two of the US FDA Oncology Center of Excellence’s newest “projects” focus on issues that pose substantial challenges in oncology drug clinical trials – use of early endpoints and enrollment of diverse patient populations.
FDA Cancer Center’s New ‘Projects’ Focus On Early Endpoints; Asian American, Native Hawaiian Populations
Launched in 2023, Project Endpoint focuses on advancing understanding of early, novel endpoints, while Project ASIATICA aims to bring greater awareness of challenges and health disparities faced by Asian American, Native Hawaiian, and Other Pacific Islander patients with cancer.
